Related Experiment Video
Updated: May 10, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Huntington's disease and cell therapies: past, present, and future
Chrystalina A Antoniades1, Colin Watts
1Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Abstract:
Huntington's disease (HD) is an inherited neurodegenerative disease that is characterized by movement abnormalities, cognitive impairment, and abnormal behavior as well as sleep and weight problems. It is an autosomal dominant disorder caused by a mutation in the huntingtin gene on the short arm of chromosome 4, which results in the progressive degeneration of the basal ganglia (caudate, putamen, and globus pallidus), cerebral cortex, brainstem, thalamus, and hypothalamus. This chapter considers four avenues of research: (a) the restoration of neurogenesis as an endogenous cell therapy in HD, (b) fetal tissue transplantation, (c) stem cell transplantation, and finally (d) the use of endogenous trophic factors such as brain derived neurotrophic factor.
Related Concept Videos
Huntington Disease l: Introduction
iPS Cell Differentiation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
EPS and iPS Cells in Disease Research
Gene Therapy
Microorganisms in Medicine and Therapeutics

